Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

A Ben-Nun, H Wekerle, IR Cohen - Nature, 1981 - nature.com
A Ben-Nun, H Wekerle, IR Cohen
Nature, 1981nature.com
Despite differences in initiating events and pathophysiology, the aetiological agents of all
autoimmune diseases are lymphocytes specifically reactive against normal constituents of
the individual. Recently we have isolated and grown as a cell line rat T lymphocytes reactive
against myelin basic protein (BP) 1. This T-cell line originated from rats in which we had
induced experimental autoimmune encephalomyelitis (EAE) by immunizing them against
BP. Inoculation of syngeneic rats with the T-cell line led to the relatively rapid onset of EAE1 …
Abstract
Despite differences in initiating events and pathophysiology, the aetiological agents of all autoimmune diseases are lymphocytes specifically reactive against normal constituents of the individual. Recently we have isolated and grown as a cell line rat T lymphocytes reactive against myelin basic protein (BP)1. This T-cell line originated from rats in which we had induced experimental autoimmune encephalomyelitis (EAE) by immunizing them against BP. Inoculation of syngeneic rats with the T-cell line led to the relatively rapid onset of EAE1. We report here that attenuation of this cell line provides an agent for establishing resistance to induction of active EAE. Intravenous (i.v.) inoculation of syngeneic rats with cells of the line attenuated by treatment with irradiation or mitomycin C augmented resistance to EAE caused by an encephalitogenic challenge with BP. Thus, aetiological agents of autoimmune disease, like those of microbial disease, when suitably attenuated can be used as effective vaccines.
nature.com